GENOMICA S.A.U. of Madrid at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option
Manufacturers Trader Service OEM

GENOMICA S.A.U.

Parque Empresarial Alvento, Edificio B Vía de los Poblados 1, 1ª Planta, 28033 Madrid
Spain
Telephone +34 91 6748990, +34 64 9270688
Fax +34 91 6748991
info@genomica.com

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

This company is co-exhibitor of
Scienion GmbH

Hall map

MEDICA 2021 hall map (Hall 3): stand A42

Fairground map

MEDICA 2021 fairground map: Hall 3

Contact

Eugenio Pinel

Director Commercial Operations

Phone
+34649270688

Email
epinel@genomica.com

José Ignacio Obeso

Clinical Applications Consultant Europe & Latam, PhD

Phone
+34686012448

Email
jobeso@genomica.com

Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Visit us

Hall 3 / A42

15 Nov 2021

Topic

all-day

Instrument Demo - Autoclart Plus

Instrument Demo - Autoclart Plus

During the entire duration of MEDICA, we will be demonstrating the capabilities of our technology at the stand.

CLART® is a low-density microarray-based platform for clinical use that allows multiple target detection in a single test. The processing of the samples is very simple and the analysis of the results is carried out automatically through software and an automatic reader (CAR® or CLINICAL ARRAY READER), which makes this technique an easy-to-use tool, allowing the implementation of this technology in all types of molecular diagnostic laboratories.

Autoclart® plus is GENOMICA's latest post-PCR automation system that combines the sample visualisation process with a Clinical Array Reader. It has been created to optimise results using CLART® technology. The new and improved interface allows programming different modes of sample processing while maintaining the ease of plug and play. During operation, the device displays different screens allowing easy step-by-step monitoring. 

Come by our stand and book a free demo with us!

More Less

16 Nov 2021

Topic

all-day

Instrument Demo - Autoclart Plus

Instrument Demo - Autoclart Plus

During the entire duration of MEDICA, we will be demonstrating the capabilities of our technology at the stand.

CLART® is a low-density microarray-based platform for clinical use that allows multiple target detection in a single test. The processing of the samples is very simple and the analysis of the results is carried out automatically through software and an automatic reader (CAR® or CLINICAL ARRAY READER), which makes this technique an easy-to-use tool, allowing the implementation of this technology in all types of molecular diagnostic laboratories.

Autoclart® plus is GENOMICA's latest post-PCR automation system that combines the sample visualisation process with a Clinical Array Reader. It has been created to optimise results using CLART® technology. The new and improved interface allows programming different modes of sample processing while maintaining the ease of plug and play. During operation, the device displays different screens allowing easy step-by-step monitoring. 

Come by our stand and book a free demo with us!

More Less

17 Nov 2021

Topic

all-day

Instrument Demo - Autoclart Plus

Instrument Demo - Autoclart Plus

During the entire duration of MEDICA, we will be demonstrating the capabilities of our technology at the stand.

CLART® is a low-density microarray-based platform for clinical use that allows multiple target detection in a single test. The processing of the samples is very simple and the analysis of the results is carried out automatically through software and an automatic reader (CAR® or CLINICAL ARRAY READER), which makes this technique an easy-to-use tool, allowing the implementation of this technology in all types of molecular diagnostic laboratories.

Autoclart® plus is GENOMICA's latest post-PCR automation system that combines the sample visualisation process with a Clinical Array Reader. It has been created to optimise results using CLART® technology. The new and improved interface allows programming different modes of sample processing while maintaining the ease of plug and play. During operation, the device displays different screens allowing easy step-by-step monitoring. 

Come by our stand and book a free demo with us!

More Less

18 Nov 2021

Topic

all-day

Instrument Demo - Autoclart Plus

Instrument Demo - Autoclart Plus

During the entire duration of MEDICA, we will be demonstrating the capabilities of our technology at the stand.

CLART® is a low-density microarray-based platform for clinical use that allows multiple target detection in a single test. The processing of the samples is very simple and the analysis of the results is carried out automatically through software and an automatic reader (CAR® or CLINICAL ARRAY READER), which makes this technique an easy-to-use tool, allowing the implementation of this technology in all types of molecular diagnostic laboratories.

Autoclart® plus is GENOMICA's latest post-PCR automation system that combines the sample visualisation process with a Clinical Array Reader. It has been created to optimise results using CLART® technology. The new and improved interface allows programming different modes of sample processing while maintaining the ease of plug and play. During operation, the device displays different screens allowing easy step-by-step monitoring. 

Come by our stand and book a free demo with us!

More Less

Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.03  Polymerase chain reaction (PCR)

Our products

Product category: Polymerase chain reaction (PCR)

qCOVID-19 Respiratory COMBO

New multiplex real-time RT PCR kit, qCOVID-19 Respiratory COMBO, available for detection and differentiation of SARS-CoV-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV A/B).
Detect and Differentiate in just 90 m inutes.

More Less

Product category: Polymerase chain reaction (PCR)

CLART HPV4, HPV4S & HPV4SHR

Genotyping of Human Papillomavirus (liquid cytology and swab without DNA extraction and FFPE tissues with extraction).
- HPV4: Full genotyping of HR and LR genotypes.
- HPV4S: Full genotyping of HR plus 6 and 11 genotypes.
- HPV4SHR: Genotyping of High Risk genotypes. Aimed for HPV screening programs worldwide.

More Less

Product category: Polymerase chain reaction (PCR)

CLART STDs

Detection and identification of 15 bacteria, viruses, parasites & fungi causing STDs.

More Less

Product category: Polymerase chain reaction (PCR)

PneumoCLART Bacteria Lyophilized

Detection and identification of 8 different respiratory bacteria.

More Less

Product category: Polymerase chain reaction (PCR)

CLART Entherpex

Simultaneous detection of the 8 most clinically important human herpesviruses and 3 viruses of the Enterovirus family in humans.

More Less

Product category: Polymerase chain reaction (PCR)

CLART Enterobac

Detection and identification of 10  bacteria causing gastrointestinal infections.

More Less

Product category: Polymerase chain reaction (PCR)

CLART Septibac

Detection and identification of Gram+, Gram– & fungi causing sepsis

More Less

About us

Company portrait

 GENOMICA is a spanish biotechnology company founded in 1990, and located in Madrid. GENOMICA is characterized by its innovation, commitment and flexibility to adapt to market needs and for being a pioneer in offering constant responses to critical situations.

GENOMICA commercializes its own CLART microarray technology, which is applied to the molecular diagnosis of infectious diseases, to personalized medicine and to the detection of biomarkers in oncology: HPV, STDs, Herpes, Sepsis, Gastrointestinal and Respiratory Infections, and Cancer Mutation Analysis. In addition, GENOMICA develops and commercialize Real Time PCR kits for Covid-19, Covid-19+FluA+FluB+RSV and FluA+FluB+RSV. GENOMICA will launch soon an innovative CLART technology, FASTCLART, for Respiratory infection, for detection and identification of 24 viruses including SARS-CoV-2. GENOMICA also offers different platforms to automate CLART technology (AutoCLART).

GENOMICA is currently present in more than 30 countries. GENOMICA has subsidiaries in Sweden and China and commercial delegates in different geographical areas.

Company data

Number of employees 50-99
Foundation 1990
Area of business
  • Imaging and diagnostics / medical equipment and devices
  • Laboratory equipment
  • Diagnostic tests